87 related articles for article (PubMed ID: 17638537)
1. A cell-based Rb(+)-flux assay of the Kv1.3 potassium channel.
Gill S; Gill R; Wicks D; Liang D
Assay Drug Dev Technol; 2007 Jun; 5(3):373-80. PubMed ID: 17638537
[TBL] [Abstract][Full Text] [Related]
2. Validation of an atomic absorption rubidium ion efflux assay for KCNQ/M-channels using the ion Channel Reader 8000.
Wang K; McIlvain B; Tseng E; Kowal D; Jow F; Shen R; Zhang H; Shan QJ; He L; Chen D; Lu Q; Dunlop J
Assay Drug Dev Technol; 2004 Oct; 2(5):525-34. PubMed ID: 15671650
[TBL] [Abstract][Full Text] [Related]
3. High-throughput screening for Kv1.3 channel blockers using an improved FLIPR-based membrane-potential assay.
Liu K; Samuel M; Tillett J; Hennan JK; Mekonnen B; Soloveva V; Harrison RK; Paslay JW; Larocque J
J Biomol Screen; 2010 Feb; 15(2):185-95. PubMed ID: 20044579
[TBL] [Abstract][Full Text] [Related]
4. Identification of novel Kv1.3 blockers using a fluorescent cell-based ion channel assay.
Slack M; Kirchhoff C; Moller C; Winkler D; Netzer R
J Biomol Screen; 2006 Feb; 11(1):57-64. PubMed ID: 16314404
[TBL] [Abstract][Full Text] [Related]
5. Identification and biochemical characterization of a novel nortriterpene inhibitor of the human lymphocyte voltage-gated potassium channel, Kv1.3.
Felix JP; Bugianesi RM; Schmalhofer WA; Borris R; Goetz MA; Hensens OD; Bao JM; Kayser F; Parsons WH; Rupprecht K; Garcia ML; Kaczorowski GJ; Slaughter RS
Biochemistry; 1999 Apr; 38(16):4922-30. PubMed ID: 10213593
[TBL] [Abstract][Full Text] [Related]
6. Development of an HTS assay for Na+, K+-ATPase using nonradioactive rubidium ion uptake.
Gill S; Gill R; Wicks D; Despotovski S; Liang D
Assay Drug Dev Technol; 2004 Oct; 2(5):535-42. PubMed ID: 15671651
[TBL] [Abstract][Full Text] [Related]
7. Functional analysis of large conductance Ca2(+)-activated K(+) channels: ion flux studies by atomic absorption spectrometry.
Parihar AS; Groebe DR; Scott VE; Feng J; Zhang XF; Warrior U; Gopalakrishnan M; Shieh CC
Assay Drug Dev Technol; 2003 Oct; 1(5):647-54. PubMed ID: 15090237
[TBL] [Abstract][Full Text] [Related]
8. Functional analysis of native and recombinant ion channels using a high-capacity nonradioactive rubidium efflux assay.
Terstappen GC
Anal Biochem; 1999 Aug; 272(2):149-55. PubMed ID: 10415083
[TBL] [Abstract][Full Text] [Related]
9. High-throughput analysis of drug binding interactions for the human cardiac channel, Kv1.5.
Karczewski J; Kiss L; Kane SA; Koblan KS; Lynch RJ; Spencer RH
Biochem Pharmacol; 2009 Jan; 77(2):177-85. PubMed ID: 18955031
[TBL] [Abstract][Full Text] [Related]
10. Rb+ efflux assay for assessment of non-selective cation channel activities.
Liu K; Samuel M; Harrison RK; Paslay JW
Assay Drug Dev Technol; 2010 Jun; 8(3):380-8. PubMed ID: 20085483
[TBL] [Abstract][Full Text] [Related]
11. Margatoxin is a non-selective inhibitor of human Kv1.3 K+ channels.
Bartok A; Toth A; Somodi S; Szanto TG; Hajdu P; Panyi G; Varga Z
Toxicon; 2014 Sep; 87():6-16. PubMed ID: 24878374
[TBL] [Abstract][Full Text] [Related]
12. Identification of a new specific Kv1.3 channel blocker, Ctri9577, from the scorpion Chaerilus tricostatus.
Xie S; Feng J; Yu C; Li Z; Wu Y; Cao Z; Li W; He X; Xiang M; Han S
Peptides; 2012 Jul; 36(1):94-9. PubMed ID: 22580271
[TBL] [Abstract][Full Text] [Related]
13. Rb+ efflux through functional activation of cardiac KCNQ1/minK channels by the benzodiazepine R-L3 (L-364,373).
Jow F; Tseng E; Maddox T; Shen R; Kowal D; Dunlop J; Mekonnen B; Wang K
Assay Drug Dev Technol; 2006 Aug; 4(4):443-50. PubMed ID: 16945016
[TBL] [Abstract][Full Text] [Related]
14. Identification of novel KCNQ4 openers by a high-throughput fluorescence-based thallium flux assay.
Li Q; Rottländer M; Xu M; Christoffersen CT; Frederiksen K; Wang MW; Jensen HS
Anal Biochem; 2011 Nov; 418(1):66-72. PubMed ID: 21782781
[TBL] [Abstract][Full Text] [Related]
15. IonFlux: a microfluidic patch clamp system evaluated with human Ether-à-go-go related gene channel physiology and pharmacology.
Golden AP; Li N; Chen Q; Lee T; Nevill T; Cao X; Johnson J; Erdemli G; Ionescu-Zanetti C; Urban L; Holmqvist M
Assay Drug Dev Technol; 2011 Dec; 9(6):608-19. PubMed ID: 21561375
[TBL] [Abstract][Full Text] [Related]
16. Ion channel pharmacology under flow: automation via well-plate microfluidics.
Spencer CI; Li N; Chen Q; Johnson J; Nevill T; Kammonen J; Ionescu-Zanetti C
Assay Drug Dev Technol; 2012 Aug; 10(4):313-24. PubMed ID: 22574656
[TBL] [Abstract][Full Text] [Related]
17. Targeting the ion channel Kv1.3 with scorpion venom peptides engineered for potency, selectivity, and half-life.
Edwards W; Fung-Leung WP; Huang C; Chi E; Wu N; Liu Y; Maher MP; Bonesteel R; Connor J; Fellows R; Garcia E; Lee J; Lu L; Ngo K; Scott B; Zhou H; Swanson RV; Wickenden AD
J Biol Chem; 2014 Aug; 289(33):22704-22714. PubMed ID: 24939846
[TBL] [Abstract][Full Text] [Related]
18. Identification of selective inhibitors of the potassium channel Kv1.1-1.2((3)) by high-throughput virtual screening and automated patch clamp.
Wacker SJ; Jurkowski W; Simmons KJ; Fishwick CW; Johnson AP; Madge D; Lindahl E; Rolland JF; de Groot BL
ChemMedChem; 2012 Oct; 7(10):1775-83. PubMed ID: 22473914
[TBL] [Abstract][Full Text] [Related]
19. Improved throughput of PatchXpress hERG assay using intracellular potassium fluoride.
Zeng H; Penniman JR; Kinose F; Kim D; Trepakova ES; Malik MG; Dech SJ; Balasubramanian B; Salata JJ
Assay Drug Dev Technol; 2008 Apr; 6(2):235-41. PubMed ID: 18471077
[TBL] [Abstract][Full Text] [Related]
20. A potent potassium channel blocker from Mesobuthus eupeus scorpion venom.
Gao B; Peigneur S; Tytgat J; Zhu S
Biochimie; 2010 Dec; 92(12):1847-53. PubMed ID: 20713119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
